303 related articles for article (PubMed ID: 24219550)
1. The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery.
Rachidi S; Aldin ES; Greenberg C; Sachs B; Streiff M; Zeidan AM
Expert Rev Hematol; 2013 Dec; 6(6):677-95. PubMed ID: 24219550
[TBL] [Abstract][Full Text] [Related]
2. Novel oral anticoagulants for the prevention of venous thromboembolism in surgical patients.
Riva N; Donadini MP; Bozzato S; Ageno W
Thromb Res; 2013 Jan; 131 Suppl 1():S67-70. PubMed ID: 23452747
[TBL] [Abstract][Full Text] [Related]
3. Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
Huisman MV; Quinlan DJ; Dahl OE; Schulman S
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):652-60. PubMed ID: 20923996
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with novel oral anticoagulants for thromboprophylaxis after elective hip and knee arthroplasty.
Messerschmidt C; Friedman RJ
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):771-8. PubMed ID: 25767271
[TBL] [Abstract][Full Text] [Related]
5. Prevention of venous thromboembolism after major orthopedic surgery: indirect comparison of three new oral anticoagulants.
Maratea D; Fadda V; Trippoli S; Messori A
J Thromb Haemost; 2011 Sep; 9(9):1868-70. PubMed ID: 21711443
[No Abstract] [Full Text] [Related]
6. Practical management of new oral anticoagulants after total hip or total knee arthroplasty.
Klauser W; Dütsch M
Musculoskelet Surg; 2013 Dec; 97(3):189-97. PubMed ID: 24249360
[TBL] [Abstract][Full Text] [Related]
7. Testing the therapeutic equivalence of novel oral anticoagulants for thromboprophylaxis in orthopedic surgery and for prevention of stroke in atrial fibrillation.
Messori A; Fadda V; Maratea D; Trippoli S; Marinai C
Int J Clin Pharmacol Ther; 2015 Mar; 53(3):211-9. PubMed ID: 25295718
[TBL] [Abstract][Full Text] [Related]
8. Relative effects of two different enoxaparin regimens as comparators against newer oral anticoagulants: meta-analysis and adjusted indirect comparison.
Kwok CS; Pradhan S; Yeong JK; Loke YK
Chest; 2013 Aug; 144(2):593-600. PubMed ID: 23519234
[TBL] [Abstract][Full Text] [Related]
9. [New direct oral anticoagulants and venous thromboprophylaxis].
Degirmenci SE; Steib A
Rev Prat; 2013 Sep; 63(7):976-9. PubMed ID: 24167901
[TBL] [Abstract][Full Text] [Related]
10. New anticoagulants for the prevention of thromboembolism.
Lepic K; Crowther M
Curr Pharm Des; 2010; 16(31):3472-4. PubMed ID: 20858184
[TBL] [Abstract][Full Text] [Related]
11. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
Quinlan DJ; Eriksson BI
Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
[TBL] [Abstract][Full Text] [Related]
12. Direct oral anticoagulants in the prevention of venous thromboembolism: evidence from major clinical trials.
Prandoni P; Temraz S; Taher A
Semin Hematol; 2014 Apr; 51(2):121-30. PubMed ID: 24861796
[TBL] [Abstract][Full Text] [Related]
13. Implications of new anticoagulants in primary practice.
Perez A; Eraso LH; Merli GJ
Int J Clin Pract; 2013 Feb; 67(2):139-56. PubMed ID: 23305476
[TBL] [Abstract][Full Text] [Related]
14. Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty.
Borris LC
Arch Orthop Trauma Surg; 2010 May; 130(5):583-9. PubMed ID: 19565250
[TBL] [Abstract][Full Text] [Related]
15. Perioperative management of patients on new oral anticoagulants.
Lai A; Davidson N; Galloway SW; Thachil J
Br J Surg; 2014 Jun; 101(7):742-9. PubMed ID: 24777590
[TBL] [Abstract][Full Text] [Related]
16. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.
Kakkos SK; Kirkilesis GI; Tsolakis IA
Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):565-75. PubMed ID: 24951377
[TBL] [Abstract][Full Text] [Related]
17. Is there a role for novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials.
Liew A; Darvish-Kazem S; Douketis JD
Pol Arch Med Wewn; 2013; 123(11):617-22. PubMed ID: 24466582
[TBL] [Abstract][Full Text] [Related]
18. Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery.
Harenberg J; Marx S; Dahl OE; Marder VJ; Schulze A; Wehling M; Weiss C
Thromb Haemost; 2012 Nov; 108(5):903-12. PubMed ID: 23014668
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.
Adam SS; McDuffie JR; Lachiewicz PF; Ortel TL; Williams JW
Ann Intern Med; 2013 Aug; 159(4):275-84. PubMed ID: 24026260
[TBL] [Abstract][Full Text] [Related]
20. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons.
Gómez-Outes A; Terleira-Fernández AI; Suárez-Gea ML; Vargas-Castrillón E
BMJ; 2012 Jun; 344():e3675. PubMed ID: 22700784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]